Clinical Trial

Cost-Effectiveness of Retromuscular Hernia Repair

Study acronym: ECOHERNIA-3
Active, Not Recruiting
View on ClinicalTrials.gov →
Summary
This prospective observational study aims to evaluate the clinical outcomes and cost-effectiveness of retromuscular midline ventral hernia repair using open, laparoscopic and robotic approaches. Patients undergoing elective repair are included and followed to assess postoperative complications, length of hospital stay, recurrence and quality of life. In addition, a cost-effectiveness analysis will be performed from the perspective of the Spanish National Health System. The study is currently ongoing.
Trial Details
NCT Number NCT07530159
Lead Sponsor Fátima Hinojosa Ramírez
Conditions Ventral Hernia Repair
Enrollment 120 participants
Start Date 2026-01-01
Primary Completion 2028-01-01 (estimated)
Study Completion 2029-01-01 (estimated)
Updated on ClinicalTrials.gov 2026-04-15